查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1525316

全球功能服務提供者市場規模研究，按類型、階段、應用和區域預測 2022-2032

Global Functional Service Providers Market Size Study, by Type, by Stage, by Application and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，全球功能服務供應商（FSP）市場估值約為144.3億美元，預計2024年至2032年將以8.49%的年複合成長率（CAGR）成長。提供關鍵支援公司透過為各種臨床開發和批准後活動提供熟練的勞動力。這些職能的外包使公司能夠專注於其核心競爭力，降低營運成本並提高藥物開發流程的效率。市場成長是由研發投資的增加和臨床試驗數量的增加所推動的。此外，人工智慧、機器學習和巨量資料分析等先進技術的採用正在增強金融服務提供者的能力。這些技術簡化了流程，提高了資料準確性，並實現了更有效率的試驗管理。

FSP 越來越多的採用主要是因為它們能夠在不影響品質或控制的情況下將固定成本轉變為變動成本。美國生物製藥產業30多年來一直處於全球領先地位，在研發方面投入巨資，滿足了對功能服務提供者的需求。此外，臨床試驗的增加和對專業服務的需求正在推動市場成長。此外，臨床試驗日益複雜和成本進一步推動了對 FSP 的需求，FSP 提供臨床監測、資料管理、統計程式設計和醫學寫作等解決方案。然而，臨床試驗的高成本和複雜性以及整合新技術的問題限制了 2024-2032 年預測期內全球功能服務提供者市場的成長。

全球功能服務供應商市場的主要區域包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。到 2023 年，北美由於其先進的醫療基礎設施、對製藥和生物技術研究的大量投資以及對專業臨床服務的高需求，在收入方面佔據市場主導地位。該地區由主要製藥公司和臨床研究組織組成的完善網路推動了 FSP 解決方案的採用。此外，北美嚴格的監管標準和對創新臨床實踐的重視也有助於其市場領先地位。臨床試驗日益複雜以及對營運效率的關注進一步增強了該地區的突出地位，使其成為全球 FSP 市場的關鍵參與者。此外，在患者人數眾多、試驗成本較低以及有利的監管政策等因素的推動下，亞太地區預計將出現最高的成長率。

目錄

第 1 章：全球功能服務供應商市場執行摘要

  • 全球功能服務供應商市場規模及預測（2022-2032）
  • 區域概要
  • 分部摘要
    • 按類型
    • 按階段
    • 按申請
  • 主要趨勢
  • 經濟衰退的影響
  • 分析師推薦與結論

第 2 章：全球功能服務提供者市場定義與研究假設

  • 研究目的
  • 市場定義
  • 研究假設
    • 包含與排除
    • 限制
    • 供給側分析
      • 可用性
      • 基礎設施
      • 監管環境
      • 市場競爭
      • 經濟可行性（消費者的角度）
    • 需求面分析
      • 監理框架
      • 技術進步
      • 環境考慮
      • 消費者意識和接受度
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第 3 章：全球功能服務供應商市場動態

  • 市場促進因素
    • 增加研發投入
    • 臨床試驗數量不斷增加
  • 市場挑戰
    • 臨床試驗成本高且複雜
    • 整合新技術的問題
  • 市場機會
    • FSP 在新興市場的擴張
    • 融合人工智慧、機器學習等先進技術

第 4 章：全球功能服務供應商市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
    • 波特五力模型的未來方法
    • 波特的五力影響分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第 5 章：全球功能服務供應商市場規模與預測：按類型 - 2022-2032

  • 細分儀表板
  • 全球功能服務供應商市場：類型收入趨勢分析，2022 年和 2032 年
    • 臨床監測
    • 醫學寫作
    • 資料管理
    • 藥物警戒
    • 生物統計學
    • 程式設計
    • 學習規劃
    • 其他

第 6 章：全球功能服務供應商市場規模與預測：按階段 - 2022-2032 年

  • 細分儀表板
  • 全球功能服務供應商市場：2022 年和 2032 年階段收入趨勢分析
    • 臨床開發
    • 批准後

第 7 章：全球功能服務供應商市場規模與預測：按應用分類 - 2022-2032

  • 細分儀表板
  • 全球功能服務供應商市場：2022 年和 2032 年應用收入趨勢分析
    • 生物製藥公司
    • 生技公司
    • 醫療器材公司

第 8 章：全球功能服務供應商市場規模與預測：按地區 - 2022-2032

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第 9 章：競爭情報

  • 重點企業SWOT分析
  • 頂級市場策略
  • 公司簡介
    • Icon Plc (Ireland)
    • PPD Inc. (US)
    • Quanticate International Limited (UK)
    • BioPoint Inc. (US)
    • RHO, Inc. (US)
    • Wuxi AppTec Co., Ltd. (China)
    • KPS Life, LLC (US)
    • IQVIA Inc. (US)
    • Laboratory Corporation of America Holdings (US)
    • Parexel International Corporation (US)

第 10 章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

The global functional service providers (FSP) market was valued at approximately USD 14.43 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.49% from 2024 to 2032. Functional service providers offer critical support to biopharmaceutical and biotechnology companies by providing a skilled workforce for various clinical development and post-approval activities. The outsourcing of these functions allows companies to focus on their core competencies, reduce operational costs, and improve efficiency in drug development processes. The market growth is driven by the increasing R&D investments and the rising number of clinical trials. Furthermore, the adoption of advanced technologies, such as artificial intelligence, machine learning, and big data analytics, is enhancing the capabilities of FSPs. These technologies streamline processes, improve data accuracy, and enable more efficient trial management.

The increasing adoption of FSPs is largely due to their ability to turn fixed costs into variable costs without compromising on quality or control. The US biopharmaceutical industry, which has been a global leader for over 30 years, invests significantly in R&D, contributing to the demand for functional service providers. Additionally, the rise in clinical trials and the need for specialized services are driving the market growth. Furthermore, the growing complexity and cost of clinical trials further fuel the demand for FSPs, which provide solutions such as clinical monitoring, data management, statistical programming, and medical writing. However, high cost and complex nature of clinical trials and issues with integrating new technologies restrain growth for the Global Functional Service Providers Market during the forecast period 2024-2032.

The key region in the Global Functional Service Providers Market includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America dominates the market in terms of revenue due to its advanced healthcare infrastructure, significant investment in pharmaceutical and biotechnology research, and high demand for specialized clinical services. The region's well-established network of major pharmaceutical companies and clinical research organizations drives the adoption of FSP solutions. Additionally, North America's stringent regulatory standards and emphasis on innovative clinical practices contribute to its market leadership. The growing complexity of clinical trials and a focus on operational efficiency further enhance the region's prominence, making it a key player in the global FSP market. Furthermore, Asia-Pacific is expected to witness the highest growth rate, driven by factors such as a high patient population, lower costs of conducting trials, and favourable regulatory policies.

Major market players included in this report are:

  • IQVIA Inc. (US)
  • Parexel International Corporation (US)
  • Laboratory Corporation of America Holdings (US)
  • Icon Plc (Ireland)
  • PPD Inc. (US)
  • Quanticate International Limited (UK)
  • BioPoint Inc. (US)
  • RHO, Inc. (US)
  • Wuxi AppTec Co., Ltd. (China)
  • KPS Life, LLC (US)

The detailed segments and sub-segment of the market are explained below:

By Type

  • Clinical Monitoring
  • Medical Writing
  • Data Management
  • Pharmacovigilance
  • Biostatistics
  • Programming
  • Study Design
  • Others

By Stage

  • Clinical Development
  • Post Approval

By Application

  • Biopharma Companies
  • Biotech Companies
  • Medical Devices Companies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Functional Service Providers Market Executive Summary

  • 1.1. Global Functional Service Providers Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Stage
    • 1.3.3. By Application
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Functional Service Providers Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Functional Service Providers Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increasing R&D investments
    • 3.1.2. Rising number of clinical trials
  • 3.2. Market Challenges
    • 3.2.1. High cost and complex nature of clinical trials
    • 3.2.2. Issues with integrating new technologies
  • 3.3. Market Opportunities
    • 3.3.1. Expansion of FSPs in emerging markets
    • 3.3.2. Integration of advanced technologies such as AI and machine learning

Chapter 4. Global Functional Service Providers Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Functional Service Providers Market Size & Forecasts by Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Functional Service Providers Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Clinical Monitoring
    • 5.2.2. Medical Writing
    • 5.2.3. Data Management
    • 5.2.4. Pharmacovigilance
    • 5.2.5. Biostatistics
    • 5.2.6. Programming
    • 5.2.7. Study Design
    • 5.2.8. Others

Chapter 6. Global Functional Service Providers Market Size & Forecasts by Stage 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Functional Service Providers Market: Stage Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Clinical Development
    • 6.2.2. Post Approval

Chapter 7. Global Functional Service Providers Market Size & Forecasts by Application 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Functional Service Providers Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Biopharma Companies
    • 7.2.2. Biotech Companies
    • 7.2.3. Medical Devices Companies

Chapter 8. Global Functional Service Providers Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Functional Service Providers Market
    • 8.1.1. U.S. Functional Service Providers Market
      • 8.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Stage breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Functional Service Providers Market
  • 8.2. Europe Functional Service Providers Market
    • 8.2.1. U.K. Functional Service Providers Market
    • 8.2.2. Germany Functional Service Providers Market
    • 8.2.3. France Functional Service Providers Market
    • 8.2.4. Spain Functional Service Providers Market
    • 8.2.5. Italy Functional Service Providers Market
    • 8.2.6. Rest of Europe Functional Service Providers Market
  • 8.3. Asia-Pacific Functional Service Providers Market
    • 8.3.1. China Functional Service Providers Market
    • 8.3.2. India Functional Service Providers Market
    • 8.3.3. Japan Functional Service Providers Market
    • 8.3.4. Australia Functional Service Providers Market
    • 8.3.5. South Korea Functional Service Providers Market
    • 8.3.6. Rest of Asia Pacific Functional Service Providers Market
  • 8.4. Latin America Functional Service Providers Market
    • 8.4.1. Brazil Functional Service Providers Market
    • 8.4.2. Mexico Functional Service Providers Market
    • 8.4.3. Rest of Latin America Functional Service Providers Market
  • 8.5. Middle East & Africa Functional Service Providers Market
    • 8.5.1. Saudi Arabia Functional Service Providers Market
    • 8.5.2. South Africa Functional Service Providers Market
    • 8.5.3. Rest of Middle East & Africa Functional Service Providers Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Icon Plc (Ireland)
    • 9.3.2. PPD Inc. (US)
    • 9.3.3. Quanticate International Limited (UK)
    • 9.3.4. BioPoint Inc. (US)
    • 9.3.5. RHO, Inc. (US)
    • 9.3.6. Wuxi AppTec Co., Ltd. (China)
    • 9.3.7. KPS Life, LLC (US)
    • 9.3.8. IQVIA Inc. (US)
    • 9.3.9. Laboratory Corporation of America Holdings (US)
    • 9.3.10. Parexel International Corporation (US)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes